Norspermidine and Novel Pd(II) and Pt(II) Polynuclear Complexes of Norspermidine as Potential Antineoplastic Agents Against Breast Cancer

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Silva, Tânia Magalhães ^a,b,c   Andersson, Sara ^b   Sukumaran, Sunil Kumar ^d   Marques, Maria Paula ^a,e   Persson, Lo ^c   Oredsson, Stina ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d Anthem Biosciences Pvt Ltd   (India)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NORSPERMIDINE; ORNITHINE DECARBOXYLASE; PALLADIUM NORSPERMIDINE COMPLEX; PLATINUM NORSPERMIDINE COMPLEX; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; ORNITHINE DECARBOXYLASE; PALLADIUM; PLATINUM; SPERMIDINE;

EID: 84873905382     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055651     Document Type: Article

References (59)

1. Simstein R, Burow M, Parker A, Weldon C, Beckman B, (2003) Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med (Maywood) 228: 995-1003.
2. Davidson NE, Hahm HA, McCloskey DE, Woster PM, Casero RA Jr, (1999) Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. Endocr Relat Cancer 6: 69-73.
3. Decatris MP, Sundar S, O'Byrne KJ, (2005) Platinum-based chemotherapy in metastatic breast cancer: the Leicester (U.K.) experience. Clin Oncol (R Coll Radiol) 17: 249-257.
4. Pegg AE, (1988) Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48: 759-774.
5. Casero RA Jr, Woster PM, (2009) Recent advances in the development of polyamine analogues as antitumor agents. J Med Chem 52: 4551-4573.
6. Agostinelli E, Marques MP, Calheiros R, Gil FP, Tempera G, et al. (2010) Polyamines: fundamental characters in chemistry and biology. Amino Acids 38: 393-403.
7. Wallace HM, Fraser AV, Hughes A, (2003) A perspective of polyamine metabolism. Biochem J 376: 1-14.
8. Takao K, Rickhag M, Hegardt C, Oredsson S, Persson L, (2006) Induction of apoptotic cell death by putrescine. Int J Biochem Cell Biol 38: 621-628.
9. Gugliucci A, (2004) Polyamines as clinical laboratory tools. Clin Chim Acta 344: 23-35.
10. Gerner EW, Meyskens FL Jr, (2004) Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 4: 781-792.
11. Wallace HM, Fraser AV, (2003) Polyamine analogues as anticancer drugs. Biochem Soc Trans 31: 393-396.
12. Wallace HM, Niiranen K, (2007) Polyamine analogues- an update. Amino Acids 33: 261-265.
13. Heinick A, Urban K, Roth S, Spies D, Nunes F, et al. (2010) Caenorhabditis elegans P5B-type ATPase CATP-5 operates in polyamine transport and is crucial for norspermidine-mediated suppression of RNA interference. FASEB J 24: 206-217.
14. Seiler N, (2005) Pharmacological aspects of cytotoxic polyamine analogs and derivatives for cancer therapy. Pharmacol Ther 107: 99-119.
15. Gonsalves RF, Kriechammer G, Marques MPM, (2011) MGBG in Combined Anticancer Chemotherapy. Lett Drug Des Discov 8: 897-903.
16. Holst CM, Frydman B, Marton LJ, Oredsson SM, (2006) Differential polyamine analogue effects in four human breast cancer cell lines. Toxicology 223: 71-81.
17. Myhre L, Alm K, Hegardt C, Staaf J, Jonsson G, et al. (2008) Different cell cycle kinetic effects of N1,N11-diethylnorspermine-induced polyamine depletion in four human breast cancer cell lines. Anticancer Drugs 19: 359-368.
18. Casero RA Jr, Woster PM, (2001) Terminally alkylated polyamine analogues as chemotherapeutic agents. J Med Chem 44: 1-26.
19. Holst CM, Staaf J, Jonsson G, Hegardt C, Oredsson SM, (2008) Molecular mechanisms underlying N1, N11-diethylnorspermine-induced apoptosis in a human breast cancer cell line. Anticancer Drugs 19: 871-883.
20. Lawley PD, Phillips DH, (1996) DNA adducts from chemotherapeutic agents. Mutat Res 355: 13-40.
21. Wang D, Lippard SJ, (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4: 307-320.
22. Lebwohl D, Canetta R, (1998) Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 34: 1522-1534.
23. Amado AM, Fiuza SM, Marques MP, Batista de Carvalho LA, (2007) Conformational and vibrational study of platinum(II) anticancer drugs: cis-diamminedichloro-platinum(II) as a case study. J Chem Phys 127: 185104.
24. de Carvalho LA, Marques MP, Martin C, Parker SF, Tomkinson J, (2011) Inelastic neutron scattering study of Pt(II) complexes displaying anticancer properties. Chemphyschem 12: 1334-1341.
25. Silva TM, Oredsson S, Persson L, Woster P, Marques MP, (2012) Novel Pt(II) and Pd(II) complexes with polyamine analogues: synthesis and vibrational analysis. J Inorg Biochem 108: 1-7.
26. Marques MP, Girao T, Pedroso De Lima MC, Gameiro A, Pereira E, et al. (2002) Cytotoxic effects of metal complexes of biogenic polyamines. I. Platinum(II) spermidine compounds: prediction of their antitumour activity. Biochim Biophys Acta 1589: 63-70.
27. Teixeira LJ, Seabra M, Reis E, da Cruz MT, de Lima MC, et al. (2004) Cytotoxic activity of metal complexes of biogenic polyamines: polynuclear platinum(II) chelates. J Med Chem 47: 2917-2925.
28. Fiuza SM, Amado AM, Oliveira PJ, Sardão VA, Batista De Carvalho LAE, et al. (2006) Pt(II) vs Pd(II) polyamine complexes as new anticancer drugs: A structure-activity study. Lett Drug Des Discov 3: 149-151.
29. Fiuza SM, Holy J, Batista de Carvalho LA, Marques MP, (2011) Biologic activity of a dinuclear Pd(II)-spermine complex toward human breast cancer. Chem Biol Drug Des 77: 477-488.
30. Miklasova N, Fischer-Fodor E, Lonnecke P, Tomuleasa CI, Virag P, et al. (2012) Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro. Eur J Med Chem 49: 41-47.
31. Hamana K, Matsuzaki S, (1982) Widespread occurrence of norspermidine and norspermine in eukaryotic algae. J Biochem 91: 1321-1328.
32. Rodriguez-Garay B, Phillips GC, Kuehn GD, (1989) Detection of Norspermidine and Norspermine in Medicago sativa L. (Alfalfa). Plant Physiol 89: 525-529.
33. Prakash NJ, Bowlin TL, Davis GF, Sunkara PS, Sjoerdsma A, (1988) Antitumor activity of norspermidine, a structural homologue of the natural polyamine spermidine. Anticancer Res 8: 563-568.
34. Bergeron RJ, Feng Y, Weimar WR, McManis JS, Dimova H, et al. (1997) A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics. J Med Chem 40: 1475-1494.
35. Holst CM, Oredsson SM, (2005) Comparison of three cytotoxicity tests in the evaluation of the cytotoxicity of a spermine analogue on human breast cancer cell lines. Toxicol In Vitro 19: 379-387.
36. Berridge MV, Tan AS, (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303: 474-482.
37. Nasizadeh S, Myhre L, Thiman L, Alm K, Oredsson S, et al. (2005) Importance of polyamines in cell cycle kinetics as studied in a transgenic system. Exp Cell Res 308: 254-264.
38. Fredlund JO, Oredsson SM, (1996) Normal G1/S transition and prolonged S phase within one cell cycle after seeding cells in the presence of an ornithine decarboxylase inhibitor. Cell Prolif 29: 457-466.
39. Begg AC, McNally NJ, Shrieve DC, Karcher H, (1985) A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620-626.
40. Fredlund JO, Johansson M, Baldetorp B, Oredsson SM, (1994) Abnormal DNA synthesis in polyamine deficient cells revealed by bromodeoxyuridine-flow cytometry technique. Cell Prolif 27: 243-256.
41. Fredlund JO, Oredsson SM, (1997) Ordered cell cycle phase perturbations in Chinese hamster ovary cells treated with an S-adenosylmethionine decarboxylase inhibitor. Eur J Biochem 249: 232-238.
42. Tummala R, Diegelman P, Fiuza SM, Batista de Carvalho LA, Marques MP, et al. (2010) Characterization of Pt-, Pd-spermine complexes for their effect on polyamine pathway and cisplatin resistance in A2780 ovarian carcinoma cells. Oncol Rep 24: 15-24.
43. Soares AS, Fiuza SM, Gonçalves MJ, Batista de Carvalho LAE, Marques MPM, et al. (2007) Effect of the Metal Center on the Antitumor Activity of the Analogous Dinuclear Spermine Chelates (PdCl2)2(Spermine) and (PtCl2)2(Spermine). Lett Drug Des Discov 4: 460-463.
44. Palmer AJ, Wallace HM, (2010) The polyamine transport system as a target for anticancer drug development. Amino Acids 38: 415-422.
45. Seiler N, Dezeure F, (1990) Polyamine transport in mammalian cells. Int J Biochem 22: 211-218.
46. Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, et al. (2012) Molecular mechanisms of cisplatin resistance. Oncogene 31: 1869-1883.
47. Huang Y, Hager ER, Phillips DL, Dunn VR, Hacker A, et al. (2003) A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells. Clin Cancer Res 9: 2769-2777.
48. Rezler EM, Fenton RR, Esdale WJ, McKeage MJ, Russell PJ, et al. (1997) Preparation, characterization, DNA binding, and in vitro cytotoxicity of the enantiomers of the platinum(II) complexes N-methyl-, N-ethyl- and N,N-dimethyl-(R)- and-(S)-3-aminohexahydroazepinedichloroplatinum(II). J Med Chem 40: 3508-3515.
49. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, et al. (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075-6086.
50. Jonsson G, Staaf J, Olsson E, Heidenblad M, Vallon-Christersson J, et al. (2007) High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization. Genes Chromosomes Cancer 46: 543-558.
51. Johannsson OT, Staff S, Vallon-Christersson J, Kytola S, Gudjonsson T, et al. (2003) Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier. Lab Invest 83: 387-396.
52. Janne J, Williams-Ashman HG, (1971) On the purification of L-ornithine decarboxylase from rat prostate and effects of thiol compounds on the enzyme. J Biol Chem 246: 1725-1732.
53. Thornthwaite JT, Sugarbaker EV, Temple WJ, (1980) Preparation of tissues for DNA flow cytometric analysis. Cytometry 1: 229-237.
54. Freiburghaus C, Janicke B, Lindmark-Mansson H, Oredsson SM, Paulsson MA, (2009) Lactoferricin treatment decreases the rate of cell proliferation of a human colon cancer cell line. J Dairy Sci 92: 2477-2484.
55. Cirenajwis H, Smiljanic S, Honeth G, Hegardt C, Marton LJ, et al. (2010) Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047. Anticancer Drugs 21: 897-906.
56. Wennerberg J, Kjellstrom J, Oredsson S, (2012) Increased toxicity of a trinuclear Pt-compound in a human squamous carcinoma cell line by polyamine depletion. Cancer Cell Int 12: 20.
57. Collins A, Dusinska M, Franklin M, Somorovska M, Petrovska H, et al. (1997) Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ Mol Mutagen 30: 139-146.
58. Johansson VM, Oredsson SM, Alm K, (2008) Polyamine depletion with two different polyamine analogues causes DNA damage in human breast cancer cell lines. DNA Cell Biol 27: 511-516.
59. Alm K, Berntsson P, Oredsson SM, (1999) Topoisomerase II is nonfunctional in polyamine-depleted cells. J Cell Biochem 75: 46-55.